Emerging Role of Consolidative Radiotherapy After Complete Remission Following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma: A Single Institutional and Case-Matched Control Study
PurposeThe role of consolidative radiotherapy (RT) after complete-remission (CR) following rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in advanced-stage diffuse large B-cell lymphoma (DLBCL) remains unclear. We retrospectively analyzed the survival out...
Main Authors: | Ji Hyun Hong, Han Hee Lee, Seung-Eun Jung, Gyeongsin Park, Joo-Hyun O, Young-Woo Jeon, Byung-Ock Choi, Seok-Goo Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.578865/full |
Similar Items
-
Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis
by: Kyu-Hye Choi, et al.
Published: (2023-08-01) -
Complete remission of primary bilateral adrenal lymphoma achieved by Rituximab-CHOP chemotherapy
by: Yang Yin-long, et al.
Published: (2011-12-01) -
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01) -
Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
by: Hongzhen Zhong, et al.
Published: (2020-10-01) -
Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
by: Xiaoyan Ma, et al.
Published: (2023-12-01)